homesitemapcontact usKorean
News & NoticeAbout usAchievementsMBRI PipelineResearch & DevelopmentCollaborations
Immunology
Oncology
Biopharmaceutical Engineering
Hematology & Endocrinology
Cord Blood Bank
■ Biopharmaceutical Engineering
Recombinant protein expression systems
Pharmaceutical Engineering
Recombinant protein expression systems

As new protein drug candidates steadily increase in number in the post-genomic era, efficient and economic protein production systems play crucial roles in the evaluation of their efficacy and commercial potential. MBRI has devoted resources to develop high output protein synthesis for pre-clinical/clinical studies of protein therapeutics in the pipeline, such as PTH, G-CSF, rhIFN-a, rhGH and rhLK8. This is achieved by employing a variety of recombinant microbial expression systems using E. coli, Saccharomyces cerevisiae, Pichia pastoris and Hansenular polymorpha.

For the development of an efficient protein production system, our efforts mainly consist of two different approaches; 1) the re-engineering of host strains by investigating the genes involved in protein folding and secretion; and 2) the process development of fermentation/purification steps.

Currently, our proprietary protein secretion system using S. cerevisiae is being further developed to improve its genetic stability and protein secretion efficiency. Moreover, the refined system is being applied to the production of the novel anti-angiogenic protein, rhLK8.
Publications

Lim, H.K., Kim, S.G., Jung, K.H., and Seo, J.H.(2004) Production of the kringle fragments of human apolipoprotein(a) by continuous lactose induction strategy. J. Biotechnol. 108, 271-278.
[PubMed Citation]

Lim, H.K., Kim, S.G., Jung, K.H., and Seo, J.H.(2004) Statistical selection of amino acids fortifying a minimal defined medium for a high-level production of the kringle fragments of human apolipoprotein(a). J. Microbiol. Biotechnol. 14, 90-96.

Lim, H.K., Lee, S.U., Chung, S.I., and Jung, K.H. (2004) Induction of the T7 promoter using lactose for production of recombinant plasminogen kringle 1-3 in Escherichia coli. J. Microbiol. Biotechnol. 14, 225-230.

Lim, H.K., Choi, S.J., Kim, K.Y., Jung, K.H. (2003) DO-stat controlling two variables for the methanol induction of rGuamerin in Pichia pastoris and its application to repeated fed-batch. Appl. Microbiol. Biotechnol. 62, 342-348.
[PubMed Citation]

Kim, K.Y., Lim, H.K., Lee, K.J., Park, D.H., Kang, K.W., Chung, S.I., and Jung, K.H. (2000) Production and characterization of recombinant Guamerin, an elastase-specific inhibitor, in the methylotrophic yeast Pichia pastoris. Protein Expr. Purif. 20, 1-9.
[PubMed Citation]

Lim, H.K., Kim, K.Y., Lee, K.J., Park, D.H., Chung, S.I. and Jung, K.H. (2000) Genetic characteristics of integrated structural gene of rGuamerin in recombinant Pichia pastoris. J. Microbiol. Biotechnol. 10, 470-475.

Lim, H.K., Park, D.H., Chung, S.I., and Jung, K.H. (2000) Production characteristics of interferon-a using an L-arabinose promoter system in a high-cell-density culture. Appl. Microbiol. Biotechnol. 53, 201-208.
[PubMed Citation]

Lim, H.K. and Jung, K.H. (1998) Improvement of heterologous protein production by controlling postinduction specific growth rate in recombinant Escherichia coli under control of the PL promoter. Biotechnol. Prog. 14, 548-553.
[PubMed Citation]